Has Trump Signed an Executive Order to Lower Drug Prices?
Click to start listening
Synopsis
In a significant move, President Trump has signed an executive order aimed at slashing drug prices in the US. This groundbreaking initiative demands that pharmaceutical companies align their prices with those in other developed countries, a step that could transform healthcare affordability in America. Dive into how this order could reshape the pharmaceutical landscape!
Key Takeaways
- Executive Order aims to lower drug prices in the US.
- Requires drug companies to match prices with developed countries.
- Health Secretary to establish direct purchasing mechanism.
- Failure to comply may lead to investigations.
- US pays significantly higher prices for prescriptions.
Washington, May 13 (NationPress) US President Donald Trump has enacted an executive order designed to reduce drug prices, mandating that pharmaceutical companies provide prices for prescription medications that are on par with those in other developed nations.
The order directs the Administration to set price benchmarks for drug manufacturers, ensuring that the United States, recognized as the largest buyer and financier of prescription drugs globally, secures the most favorable deals.
Health and Human Services Secretary Robert F. Kennedy Jr. will create a system allowing American patients to purchase their medications directly from manufacturers, who will offer a “Most-Favored-Nation” price, eliminating intermediaries.
“We are committed to paying the lowest price available worldwide. We will access the lowest price that is being paid,” Trump stated to the press at the White House on Monday, prior to his trip to the Middle East.
Trump emphasized that drug manufacturers must align their US prices with those of other developed countries or risk facing investigations, as reported by the Xinhua news agency.
Recent statistics reveal that the costs incurred by Americans for brand-name drugs exceed three times the prices paid by other OECD nations, even when accounting for discounts provided by manufacturers in the US, as highlighted in the order.
OECD stands for the Organisation for Economic Co-operation and Development, primarily composed of developed nations.
The US accounts for less than five percent of the global population but contributes approximately 75 percent of the world’s pharmaceutical profits, according to the order.
Point of View
It is crucial to highlight that President Trump's recent executive order on drug pricing represents a significant shift in America's approach to healthcare. This move, aimed at ensuring fair pricing for pharmaceuticals, could potentially benefit millions of Americans and reshape the pharmaceutical landscape, making it essential for us to monitor its implementation closely.
NationPress
11/06/2025
Frequently Asked Questions
What is the purpose of Trump's executive order?
The executive order seeks to reduce drug prices in the US by requiring pharmaceutical companies to offer prices comparable to those in other developed nations, ensuring Americans receive the best deals.
Who will oversee the implementation of this order?
Health and Human Services Secretary Robert F. Kennedy Jr. will be responsible for establishing a system that allows patients to buy medications directly from manufacturers at a 'Most-Favored-Nation' price.
What are the consequences for drug companies if they do not comply?
Drug manufacturers that do not adjust their US prices to align with those in other developed countries may face investigations.
How do US drug prices compare with other countries?
Americans pay more than three times the price for brand-name drugs compared to other OECD nations, even after accounting for discounts.
What is the OECD?
The OECD, or Organisation for Economic Co-operation and Development, is an organization primarily made up of developed nations that collaborate to promote policies that improve economic and social well-being worldwide.
